Page last updated: 2024-10-30

beta-lapachone and Candidiasis

beta-lapachone has been researched along with Candidiasis in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
da Silva, CR1
S Campos, R1
de A Neto, JB1
Sampaio, LS1
do Nascimento, FB1
do Av Sá, LG1
Cândido, TM1
Magalhães, HI1
da Cruz, EH1
da Silva Júnior, EN1
de Moraes, MO1
Cavalcanti, BC1
Silva, J1
Marinho, ES1
Júnior, HV1

Other Studies

1 other study available for beta-lapachone and Candidiasis

ArticleYear
Antifungal activity of β-lapachone against azole-resistant
    Future microbiology, 2020, Volume: 15

    Topics: Antifungal Agents; Azoles; Biofilms; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbia

2020